Marksans Pharma share price target
About Marksans Pharma :
Marksans Pharma Ltd. become incorporated within the yr 1992. Its brand new share price is 58.05. Its cutting-edge marketplace capitalisation stands at Rs 2376.07 Cr. in the latest sector, business enterprise has mentioned Gross income of Rs. 5995.48 Cr and total income of Rs.6307.03 Cr. The enterprise‘s management includes Sunny Sharma, Harshavardhan Panigrahi, Meena Surana, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.
it is listed on the BSE with a BSE Code of 524404 , NSE with an NSE symbol of MARKSANS and ISIN of INE750C01026. it’s Registered workplace is at eleventh floor, ” Grandeur “,Opp. Gundecha Symphony, Veera Desai Extension avenue,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are ACC Ltd. it’s auditors are Bhuta Shah & Co LLP, NK Mittal & buddies, VS Lalpuria & Co
| Mkt cap | 2.38TCr |
| 52-wk high | 97.60 |
| 52-wk low | 49.00 |
| P/E ratio | 9.71 |
| Div yield | 0.43% |
Share Target Price 2022 2023 2025 2030 of Marksans Pharma
Show 102550100 entriesSearch:
| Year | Min | Max |
|---|---|---|
| 2022 | 63 | 71 |
| 2023 | 74 | 85 |
| 2024 | 88 | 97 |
| 2025 | 109 | 125 |
| 2026 | 131 | 149 |
| 2027 | 157 | 172 |
| 2028 | 170 | 195 |
| 2029 | 201 | 226 |
| 2030 | 245 | 275 |
Also read – Tata chemical share price target 2022 2023 2024 2025 2030
FAQ – Fundamental
Is MARKSANS PHARMA correct for long time investment?
As on 17-Dec-2021, the fundamentals of MARKSANS PHARMA appearance robust and for this reason it can be precise for long time investment! See economic overall performance of MARKSANS PHARMA . Please observe the alternative parameters together with Valuation, rate Momentum, information & company Governance and/or consult an investment advisor earlier than taking an investment choice!
Is MARKSANS PHARMA UnderValued or overestimated?
As on 17-Dec-2021, MARKSANS PHARMA is fairly Valued primarily based at the estimates of intrinsic fee and traders may also wait for the buying opportunity as soon as it turns into underneath valued!
also read – RBL bank share price target 2022 2023 2024 2025 2030
what is the Intrinsic value of MARKSANS PHARMA ?
As on 17-Dec-2021, the Intrinsic value of MARKSANS PHARMA is Rs. 57.69 decided based on Median of the 3 historical models.
fair cost [Median EV / EBIDTA Model] : Rs. 118.36
honest price [Median EV / Sales Model] : Rs. 57.69
honest cost [Median Price / Sales Model] : Rs. 49.99
Median honest fee of MARKSANS PHARMA : Rs. 57.69
Is MARKSANS PHARMA trading at a top rate or cut price?
As on 17-Dec-2021, MARKSANS PHARMA is trading at a top class of 1% based on the estimates of Median Intrinsic value!